Oral Delivered Dexmedetomidine Promotes and Consolidates Non-rapid Eye Movement Sleep via Sleep–Wake Regulation Systems in Mice
Dexmedetomidine, a highly selective α2-adrenergic agonist, is widely used in clinical anesthesia and ICU sedation. Recent studies have found that dexmedetomidine-induced sedation resembles the recovery sleep that follows sleep deprivation, but whether orally delivered dexmedetomidine can be a candid...
Main Authors: | Zhen-Xin Feng, Hui Dong, Wei-Min Qu, Wei Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.01196/full |
Similar Items
-
Non-rapid eye movement sleep and wake neurophysiology in schizophrenia
by: Nataliia Kozhemiako, et al.
Published: (2022-05-01) -
Effect of Dexmedetomidine on Postoperative Sleep Quality: A Systematic Review
by: Huang X, et al.
Published: (2021-05-01) -
Editorial: The Gating and Maintenance of Sleep and Wake: New Circuits and Insights
by: Michael Lazarus, et al.
Published: (2020-08-01) -
Patient Sleep- wake rhythms in hospital
by: Tootoonchi M
Published: (1991-03-01) -
Dynamics of sleep-wake cyclicity at night across the human lifespan
by: Hrönn Arnardóttir, et al.
Published: (2010-12-01)